What is the difference in severity of paediatric coronavirus disease 2019?

Kasuga, Yuki; Kanezawa, Koji; Shimizu, Shoichi; Nakazaki, Kimitaka; Go, Hidetoshi; Nishimura, Koji; Morioka, Ichiro

Kasuga, Yuki; Kanezawa, Koji; Shimizu, Shoichi; Nakazaki, Kimitaka; Go, Hidetoshi; Nishimura, Koji; Morioka, Ichiro.

Kasuga Y; Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Kanezawa K; Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Shimizu S; Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Nakazaki K; Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Go H; Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Nishimura K; Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Morioka I; Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.

Acta Paediatr ; 110(5): 1687-1688, 2021 05.

Article in English | MEDLINE | ID: covidwho-730092

Subject(s)

COVID-19; Systemic Inflammatory Response Syndrome; Child; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Systemic Inflammatory Response Syndrome / COVID-19 Type of study: Prognostic study Limits: Child / Humans Language: English Journal: Acta Paediatr Year: 2021 Document Type: Article Affiliation country: Apa.15499

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google